Marinomed Biotech AG started trading on the prime market, the top segment of the Vienna Stock Exchange on 1 February 2019. The IPO of Marinomed Biotech AG was the first in Europe this year. The start of trading was traditionally celebrated with the bell-ringing ceremony: The Marinomed management board Andreas Grassauer (CEO), Eva Prieschl-Grassauer (CSO) and Pascal Schmidt (CFO) rang the bell together with Vienna Stock Exchange CEO Christoph Boschan.
All Videos at a Glance
150 anniversary Prague Stock Exchange
250 anniversary Vienna Stock Exchange
Vienna Stock Exchange Award 2021
ATX or ATX TR – the dividend makes the difference
Austrian Stock Talk
Future Forum
Vienna Stock Exchange Award 2020
Excellence for debt securities
First trading day of Addiko Bank AG
Delivering a world of good deals
IPO of Frequentis AG
Thinking AUT Loud | The Sound of Finance
IPO of Marinomed Biotech AG
FESE Convention 2018
direct market plus – Easy access to the capital market
Vienna Stock Exchange Award 2018: The Oscar of the financial community goes to CA Immo
ETF trading at the Vienna Stock Exchange
IPO of BAWAG Group AG
ATX, CECE & Co. – Index know-how of the Vienna Stock Exchange
Vienna Stock Exchange Award 2017: The Oscar of the financial community goes to voestalpine
Stocks and Bonds: Listing on the Vienna Stock Exchange
Going Public: Boost for innovation & growth
